-
Publication Venue For
-
Cord blood derived cell therapy product, DUOC-01, accelerates remyelination in a murine model of cuprizone induced demyelination.
17:S55-S55.
2015
-
Human cord blood derived CD14 cell therapy provides neuroprotection in aquired brain injury.
17:S57-S57.
2015
-
Neural engraftment of a cord blood-derived cell product following intrathecal transplantation.
17:S56-S56.
2015
-
The use of hydroxyethyl starch (HES) as a substitute for dextran 40 in the thaw and washing of HPC, apheresis products.
17:S60-S60.
2015
-
DUOC-01, A CANDIDATE CELL THERAPY PRODUCT DERIVED FROM BANKED CORD BLOOD, ACCELERATES BRAIN REMYELINATION IN NSG MICE FOLLOWING CUPRIZONE FEEDING.
16:S61-S62.
2014
-
Neuronal and glial cell composition in a mouse brain slice culture model is useful in developing human cord blood derived cellular therapies for neonatal hypoxic-ischemic brain injury.
16:S61-S61.
2014
-
PROTECTION OF BRAIN CELLS IN ORGANOTYPIC SLICE CULTURES EXPOSED TO OXYGEN AND GLUCOSE DEPRIVATION IS SPECIFICALLY MEDIATED BY CORD BLOOD CD14+CELLS.
16:S61-S61.
2014
-
Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases.
16:S16-S17.
2014
-
Tissue distribution of a cord blood-derived cell product following intrathecal transplantation.
16:S63-S63.
2014
-
Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood..
9:569-576.
2007
-
Modification of a commercial cell sorter to support efficient and reliable preparation of ALDH-bright cells for clinical use..
9:562-568.
2007
-
AML-loaded DC generate Th1-type cellular immune responses in vitro..
8:95-104.
2006
-
Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.
8:580-588.
2006
-
Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting..
7:126-133.
2005
-
Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal..
6:328-336.
2004
-
DUOC-01, a cord blood derived cell therapy product, ameliorates experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis
2020
-
Developing a novel thymus organoid as a cell therapy to correct autoimmunities
2020
-
Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates with Hypoxic-Ischemic Encephalopathy
2020
-
Reprogramming inflammatory macrophages with mesenchymal stromal cells
2020
-
Human umbilical cord blood derived cell therapy product, DUOC-01, ameliorates experimental autoimmune encephalomyelitis, a mouse model for multiple sclerosis
2019
-
Meeting the demands of msc production for clinical studies
2019
-
MANUFACTURING OF ALLOGENEIC HUMAN CORD TISSUE MESENCHYMAL STROMAL CELLS: INITIAL RESULTS OF A PHASE I CLINICAL TRIAL IN CHILDREN WITH AUTISM SPECTRUM DISORDER
2018
-
TARGETING NEUROINFLAMMATION WITH HUMAN UMBILICAL CORD TISSUE-DERIVED MESENCHYMAL STROMAL CELLS
2018
-
TOWARDS A MECHANISM-BASED POTENCY ASSAY FOR CORD BLOOD UNITS IN TREATMENT OF HYPOXIC-ISCHEMIC BRAIN DAMAGE
2018
-
CHARACTERIZATION OF MSC DERIVED FROM UMBILICAL CORD TISSUES
2017
-
UMBILICAL CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS INHIBIT LYSOPHOSPHATIDYLCHOLINE MEDIATED ACTIVATION OF MICROGLIA IN ORGANOTYPIC CEREBELLAR CULTURES
2017
-
Aldehyde dehydrogenase, but not viability of CD34 cells, predicts potency and engraftment after cord blood transplantation
2015
-
Experience in a public cord blood bank using a segment-based aldehyde dehydrogenase assay as a biomarker for umbilical cord blood potency
2014